BATS:ARKG ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News $21.52 -2.09 (-8.87%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$21.51 -0.01 (-0.03%) As of 03/28/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock About ARK Genomic Revolution ETF (BATS:ARKG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get ARKG alerts:Sign Up Key Stats Today's Range$24.20▼$25.2450-Day Range$21.52▼$29.7952-Week Range$21.37▼$31.16Volume4.90 million shsAverage Volume2.68 million shsMarket Capitalization$1.02 billionAssets Under Management$983.29 millionDividend YieldN/ANet Expense Ratio0.75%Aggregate RatingModerate Buy ETF OverviewThe ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.Read More… Remove Ads ARK Genomic Revolution ETF ExpensesTypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.75%0.57%0.56%0.57%0.53%Other Expenses0.00%0.57%0.49%0.45%0.52%Total Expense0.75%0.73%0.72%0.69%0.71%Fee Waiver0.00%-0.72%-0.50%-0.34%-0.55%Net Expense0.75%0.60%0.63%0.64%0.60% Receive ARKG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address ARKG ETF News HeadlinesMarket sell-off shakes ETF issuers as Ark Invest gets hit the hardestMarch 18, 2025 | msn.com908 Devices Makes Key Divestiture (Rating Upgrade)March 6, 2025 | seekingalpha.com$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.March 29, 2025 | Stansberry Research (Ad)HC Wainwright & Co. Initiates Coverage of Intellia Therapeutics (NTLA) with Buy RecommendationMarch 5, 2025 | msn.comARK Invest Europe Prepares to Close Rize Digital Payments ETFFebruary 20, 2025 | finance.yahoo.comUnusually active option classes on open February 18thFebruary 18, 2025 | markets.businessinsider.comSee More Headlines ARKG ETF - Frequently Asked Questions How have ARKG shares performed this year? ARK Genomic Revolution ETF's stock was trading at $23.5450 at the beginning of 2025. Since then, ARKG shares have decreased by 8.6% and is now trading at $21.5160. View the best growth stocks for 2025 here. Who are ARK Genomic Revolution ETF's major shareholders? ARK Genomic Revolution ETF's top institutional shareholders include JPMorgan Chase & Co. (4.94%), IMC Chicago LLC, Two Sigma Investments LP (1.70%) and LPL Financial LLC (1.22%). How do I buy shares of ARK Genomic Revolution ETF? Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of ARK Genomic Revolution ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that ARK Genomic Revolution ETF investors own include Invesco QQQ (QQQ), ARK Innovation ETF (ARKK), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AbbVie (ABBV) and PayPal (PYPL). Fund Details IssuerARK Fund NameARK Genomic Revolution ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:ARKG Inception Date10/31/2014 Fund ManagerCatherine Wood WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings35 Fund Statistics Assets Under Management$983.29 million Average Daily Volume$3.69 million Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorThe Bank of NewYork Mellon Corporation AdvisorARK Investment Management LLC CustodianThe Bank of NewYork Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of NewYork Mellon Corporation TrusteeN/A Lead Market MakerJane Street Options OptionableOptionable Options Volume11,972 Put Options7,993 Call Options3,979 Miscellaneous Outstanding Shares47,400,000Beta1.64 Creation Unit50,000 Creation Fee$500.00 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report Top 10 ARKG HoldingsTwist Bioscience (NASDAQ:TWST)Holding Weight: 8.66%CRISPR Therapeutics (NASDAQ:CRSP)Holding Weight: 8.44%Recursion Pharmaceuticals (NASDAQ:RXRX)Holding Weight: 7.30%Tempus AI (NASDAQ:TEM)Holding Weight: 6.45%Natera (NASDAQ:NTRA)Holding Weight: 5.61%Guardant Health (NASDAQ:GH)Holding Weight: 5.54%Adaptive Biotechnologies (NASDAQ:ADPT)Holding Weight: 5.36%Schrödinger (NASDAQ:SDGR)Holding Weight: 4.86%Beam Therapeutics (NASDAQ:BEAM)Holding Weight: 4.80%CareDx (NASDAQ:CDNA)Holding Weight: 4.08%Full Holdings DetailsARKG Sector ExposureARKG Industry Exposure This page (BATS:ARKG) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARKG Stock Free ARKG Stock Alerts